Skip to Main Content

Paper Details

A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy.
Br J Cancer
8
2020
Author NameAffiliation
Hartwig HulandMartini-Klinik Prostate Cancer Center, University Medical Center Hamburg-Eppendorf
Markus GraefenMartini-Klinik Prostate Cancer Center, University Medical Center Hamburg-Eppendorf
Thorsten SchlommCharite - Universitatsmedizin Berlin
Guido SauterInstitute of Pathology, University Medical Center Hamburg-Eppendorf
  • 1 - 4

Datasets

Release 1.2